Evidence for mast cells contributing to neuromuscular pathology in an inherited model of ALS
Year: 2017
Type: article
Abstract: Evidence indicates that neuroinflammation contributes to motor neuron degeneration in amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease leading to progressive muscular paralysis. However, it remains elusive whether inflammatory cells can interact with degenerating distal motor axons, influencing the progressive denervation of neuromuscular junctions (NMJs). By analyzing the muscle extensor digitorum longus (EDL) following paralysis onset in the SOD1G93A rat model, we have observed a massive infiltration and degranulation of mast cells, starting after paralysis onset and correlating with progressive NMJ denervation. Remarkably, mast cells accumulated around degenerating motor axons and NMJs, and were also associated with macrophages. Mast cell accumulation and degranulation in paralytic EDL muscle was prevented by systemic treatment over 15 days with masitinib, a tyrosine kinase inhibitor currently in clinical trials for ALS exhibiting pharmacological activity affecting mast cells and microglia. Masitinib-induced mast cell reduction resulted in a 35% decrease in NMJ denervation and reduced motor deficits as compared with vehicle-treated rats. Masitinib also normalized macrophage infiltration, as well as regressive changes in Schwann cells and capillary networks observed in advanced paralysis. These findings provide evidence for mast cell contribution to distal axonopathy and paralysis progression in ALS, a mechanism that can be therapeutically targeted by masitinib.
Source: JCI Insight
Institutions: Institut Pasteur de Montevideo, Hôpital Necker-Enfants Malades, Centre National de la Recherche Scientifique, Inserm, Université Paris Cité, Sorbonne Paris Cité, Laboratory of Excellence GR-Ex, La Ligue Contre le Cancer, Institut des Maladies Génétiques Imagine, Laboratoire d'hématologie, Aix-Marseille Université, AB Science (France), Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Oregon State University
Language: German
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $4,100
OpenAlex ID: W2766795446
